ML-365

N/A

Report date: 2023/02/18 19:35:17
NME

Base Information

Drug NameML-365
Drug Alias NameML-365
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTandem pore domain potassium channels inhibitors
TargetsTandem pore domain potassium channels
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesJohns Hopkins University
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A